SCENESSE ® (afamelanotide) implant is a prescription medication indicated to increase pain-free light exposure in adult patients with a history of phototoxic reactions from erythropoietic …

SCENESSE® (pronounced “sen-esse”) acts by increasing the levels of eumelanin in the skin, shielding against UV radiation (UVR) and visible light, including sunlight. Afamelanotide is a …

Darkening of pre-existing nevi and ephelides may occur with use of SCENESSE®. A full body examination is recommended twice yearly to monitor pre-existing and new skin pigmentary …

FOR HEALTHCARE PROFESSIONALS: Information on the SCENESSE® administration procedure.

SCENESSE may lead to generalized increased skin pigmentation and darkening of pre-existing nevi and ephelides because of its pharmacologic effect. A full body skin examination (twice …

The safety of SCENESSE® was evaluated in 3 randomized, multicenter, prospective, vehicle controlled clinical trials (Study CUV029, Study CUV030, and Study CUV039) involving 244 …

Darkening of pre-existing nevi and ephelides may occur with use of SCENESSE®. A full body examination is recommended twice yearly to monitor pre-existing and new skin pigmentary …

SCENESSE is a melanocortin 1 receptor (MC1-R) agonist indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic …

To stay up to date on news about SCENESSE® and EPP, subscribe to our mailing list or send us an enquiry.

Darkening of pre-existing nevi and ephelides may occur with use of SCENESSE®. A full body examination is recommended twice yearly to monitor pre-existing and new skin pigmentary …